Your browser doesn't support javascript.
loading
Characterizing hepatitis B virus infection in children in the Democratic Republic of Congo to inform elimination efforts.
Morgan, C E; Powers, K A; Edwards, J K; Devkota, U; Biju, S; Lin, F C; Schmitz, J L; Cloherty, G; Muwonga, J; Mboyo, A; Tshiamala, P; Kashamuka, M M; Tshefu, A; Emch, M; Yotebieng, M; Becker-Dreps, S; Parr, J B; Thompson, P.
Afiliação
  • Morgan CE; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA.
  • Powers KA; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA.
  • Edwards JK; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA.
  • Devkota U; University of North Carolina, Chapel Hill, NC, USA.
  • Biju S; University of North Carolina, Chapel Hill, NC, USA.
  • Lin FC; Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA.
  • Schmitz JL; Department of Pathology & Laboratory Medicine, UNC School of Medicine, Chapel Hill, NC, USA.
  • Cloherty G; Abbott Laboratories, Abbott, IL, USA.
  • Muwonga J; Programme National de Lutte Contre le SIDA, Kinshasa, Democratic Republic of Congo.
  • Mboyo A; Programme National de Lutte Contre le SIDA, Kinshasa, Democratic Republic of Congo.
  • Tshiamala P; National Hepatitis Control Program, Kinshasa, Democratic Republic of Congo.
  • Kashamuka MM; École de Santé Publique, Université de Kinshasa, Kinshasa, Democratic Republic of Congo.
  • Tshefu A; École de Santé Publique, Université de Kinshasa, Kinshasa, Democratic Republic of Congo.
  • Emch M; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA.
  • Yotebieng M; Division of General Internal Medicine, Department of Medicine, Albert Einstein College of Medicine, Bronx, NY, USA.
  • Becker-Dreps S; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA.
  • Parr JB; Department of Family Medicine, UNC School of Medicine, University of North Carolina, Chapel Hill, NC, USA.
  • Thompson P; Division of Infectious Diseases, Department of Medicine, UNC School of Medicine, University of North Carolina, Chapel Hill, NC, USA.
medRxiv ; 2024 Jun 13.
Article em En | MEDLINE | ID: mdl-38947057
ABSTRACT

Objective:

Despite global reductions in hepatitis B virus (HBV) prevalence, an estimated 6.2 million children are infected, two-thirds of whom live in the WHO Africa region. We sought to characterize childhood HBV to inform elimination efforts in the Democratic Republic of Congo (DRC), one of the largest and most populous African countries.

Methods:

Using the most recent (2013-14) nationally representative Demographic and Health Survey in the DRC, we analyzed HBV surface antigen (HBsAg) on dried blood spots and associated survey data from children aged 6-59 months. We estimated HBsAg-positivity prevalence nationally, regionally, and by potential correlates of infection. We evaluated spatial variation in HBsAg-positivity prevalence, overall and by age, sex, and vaccination status.

Findings:

Using data from 5,679 children, we found national HBsAg-positivity prevalence was 1.3% (95% CI 0.9%-1.7%), but ranged from 0.0% in DRC's capital city province, Kinshasa, to 5.6% in northwestern Sud-Ubangi Province. Prevalence among boys (1.8%, 95% CI 1.2%-2.7%) was double that among girls (0.7%, 95%CI 0.4%-1.3%). Tetanus antibody-negativity, rurality, and lower household wealth were also significantly associated with higher HBsAg-positivity prevalence. We observed no difference in prevalence by age. Children had higher HBsAg-positivity odds if living with ≥1 HBsAg-positive adult household member (OR 2.3, 95%CI 0.7-7.8), particularly an HBsAg-positive mother (OR 7.2, 95%CI1.6-32.2).

Conclusion:

In the largest national survey of HBV among children and household contacts in the DRC, we found that childhood HBV prevalence was 10-60 times the global target of 0.1%. We highlight specific regions and populations for further investigation and focused prevention efforts.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: MedRxiv Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: MedRxiv Ano de publicação: 2024 Tipo de documento: Article